Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 4816.T
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -4.27 4.19 4.38
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -22.79 -13.58 -11.06
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 5.12 644.18 612.82
Cash 9.13 386.82 354.47
Capex 0.00 0.00 0.00
Free Cash Flow inf 0.00 2.00
Revenue 2.89 105.33 102.37
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -6.12 0.44 0.47
Operating Margin -15.18 0.26 0.31
ROA -9.18 0.03 0.03
ROE -8.16 0.03 0.03
ROIC -19.38 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 4816.T is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 4816.T is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 4816.T is permitted for members.